As of 2025-09-16, the Relative Valuation of Innocan Pharma Corp (INNO.CN) is 1.47 CAD. This relative valuation is based on P/E multiples. With the latest stock price at 12.00 CAD, the upside of Innocan Pharma Corp based on Relative Valuation is -87.8%.
The range of the Relative Valuation is (0.04) - 4.78 CAD.
| Range | Selected | |
| Trailing P/E multiples | 0.1x - 2.0x | 0.1x |
| Forward P/E multiples | 7.6x - 15.2x | 9.5x |
| Fair Price | (0.04) - 4.78 | 1.47 |
| Upside | -100.3% - -60.2% | -87.8% |
| Date | P/E |
| 2025-09-09 | -36.87 |
| 2025-09-08 | -37.46 |
| 2025-09-05 | -38.19 |
| 2025-09-04 | -36.28 |
| 2025-09-03 | -35.33 |
| 2025-09-02 | -42.01 |
| 2025-08-29 | -40.10 |
| 2025-08-28 | -40.10 |
| 2025-08-27 | -40.10 |
| 2025-08-26 | -40.10 |
| 2025-08-25 | -39.15 |
| 2025-08-22 | -40.10 |
| 2025-08-21 | -40.10 |
| 2025-08-20 | -40.10 |
| 2025-08-19 | -42.01 |
| 2025-08-18 | -42.97 |
| 2025-08-15 | -42.97 |
| 2025-08-14 | -42.01 |
| 2025-08-13 | -43.92 |
| 2025-08-12 | -42.01 |
| 2025-08-11 | -43.92 |
| 2025-08-08 | -42.97 |
| 2025-08-07 | -43.92 |
| 2025-08-06 | -43.92 |
| 2025-08-05 | -44.87 |
| 2025-08-01 | -45.83 |
| 2025-07-31 | -45.83 |
| 2025-07-30 | -45.83 |
| 2025-07-29 | -43.92 |
| 2025-07-28 | -45.83 |
| 2025-07-25 | -44.87 |
| 2025-07-24 | -45.83 |
| 2025-07-23 | -40.10 |
| 2025-07-22 | -40.10 |
| 2025-07-21 | -34.37 |
| 2025-07-18 | -40.10 |
| 2025-07-17 | -40.10 |
| 2025-07-16 | -40.10 |
| 2025-07-15 | -40.10 |
| 2025-07-14 | -40.10 |
| 2025-07-11 | -40.10 |
| 2025-07-10 | -40.10 |
| 2025-07-09 | -41.06 |
| 2025-07-08 | -40.10 |
| 2025-07-07 | -42.97 |
| 2025-07-04 | -43.92 |
| 2025-07-03 | -45.83 |
| 2025-07-02 | -42.01 |
| 2025-06-30 | -42.97 |
| 2025-06-27 | -42.97 |